Sildenafil Tablet, Film Coated
Product Images NDC 50090-5236

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 50090-5236). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Figure1)

A cumulative mortality rate curve chart comparing estimated mortality rates over time for three dosage groups labeled as High dose, Medium dose, and Low dose. The graph includes a 'Number at Risk' table above the curves showing decreasing numbers of subjects in each dose group at various time points.*

FDA Label Image

Figure2 (Figure2)

A chart illustrating drug interaction effects on Sildenafil, showing the fold change and 90% confidence interval for AUC and Cmax values relative to Sildenafil alone. It lists interacting drugs on the left, fold change values across the horizontal axis, and dosing recommendations on the right, indicating most drugs require no dose adjustment except Ritonavir, where coadministration is not recommended.*

FDA Label Image

Figure3 (Figure3)

A horizontal dot plot chart showing fold change and 90% confidence intervals in pharmacokinetic parameters (AUC, Cmax, INR AUC, INR Cmax, BT) of Sildenafil when coadministered with various interacting drugs including Acenocoumarol, Aspirin, Atorvastatin, Bosentan, three doses of Doxazosin, Ethinyloestradiol, Levonorgestrel, Phenprocoumon, Ritonavir, Saquinavir, and Tolbutamide. The chart includes a vertical reference line at 1 representing no change and annotations indicating dose adjustment recommendations for each coadministered drug.*

FDA Label Image

Figure4 (Figure4)

A chart illustrating the change from baseline in a measured variable over study weeks 4, 8, and 12. The graph compares results for three groups: Sildenafil 40 mg TID, Placebo, and Sildenafil 80 mg TID, with error bars indicating variability within each group at each time point.*

FDA Label Image

Figure5 (Figure5)

A forest plot chart comparing placebo and Sildenafil 20 mg TID groups, displaying baseline walk distance, etiology, pulmonary hypertension criteria, gender, age, mean PAP, and PVRI with corresponding mean values, sample sizes, and confidence intervals for changes in 6-minute walk distance corrected for placebo.*

FDA Label Image

Figure6 (Figure6)

A line chart comparing the percentage of participants without a clinically worsening event over a period of 112 days after randomization. Two lines represent groups taking Sildenafil and a placebo, with the Sildenafil group showing a higher percentage without worsening events throughout the timeline.*

FDA Label Image

Figure7 (Figure7)

A line graph showing mean change from baseline in meters measured over weeks 4, 8, and 12 of a study. The graph compares three Sildenafil tablet doses (1 mg TID, 5 mg TID, and 20 mg TID) with error bars representing standard error at each time point.*

FDA Label Image

Structure (Structure)

Chemical structure of Sildenafil, showing its molecular framework including ring systems and functional groups consistent with the active ingredient Sildenafil.*

FDA Label Image

Camber1 (Camber1)

FDA Label Image

Camber2 (Camber2)

FDA Label Image

Image1 (Image1)

A line plot showing the mean change in baseline measured in meters over a 12-week study period for Sildenafil doses of 1 mg TID, 5 mg TID, and 20 mg TID. The y-axis represents change from baseline in meters, ranging from -10 to 70, and the x-axis shows weeks 4, 8, and 12. Data points include error bars indicating standard error for each treatment at each time point.*

FDA Label Image

Label Image (Lbl500905236)

Sildenafil 20 mg film-coated tablets packaging label from A-S Medication Solutions. The label displays the dosage strength of 20 mg, product and lot numbers, storage instructions to keep between 68 and 77 degrees Fahrenheit, and a count of 30 tablets. The label also includes directions to see the package insert for dosing information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.